Stay updated on Long-term Exenatide Use Clinical Trial
Sign up to get notified when there's something new on the Long-term Exenatide Use Clinical Trial page.

Latest updates to the Long-term Exenatide Use Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical investigation related to Type 2 Diabetes and exenatide therapy, while a new registry identifier has been added.SummaryDifference9%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check70 days agoChange DetectedThe mention of 'AstraZeneca' has been added, while the specific reference to 'AstraZeneca K.K.' has been removed. Additionally, a notice regarding service performance and availability has been deleted.SummaryDifference2%
- Check91 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check98 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Long-term Exenatide Use Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Exenatide Use Clinical Trial page.